top of page

Case Study



Market Opportunity


Companies with innovative products often lack resources and networks to expand globally


Our Solution


Incubated, capitalized, established and managed a global medical devices marketing and distribution company that takes exclusive licenses for such products and solutions

Performance Within Two Years


Built global distribution for 1st product, Altrazeal®, under license in over 50 countries

On March 31, 2017, Velocitas made a direct investment in ULURU Inc., the parent company of Altrazeal®, in order to further accelerate its growth and international expansion.


For more information please visit ULURU Inc.'s website at

bottom of page